Loading
institutionsInstitution
Fondazione AIRC per la ricerca sul cancro
Italy's main charitable funder of cancer research, supporting thousands of investigators at IEO, the Istituto Nazionale dei Tumori and universities nationwide.
Also called: AIRCAssociazione Italiana per la Ricerca sul Cancro
Overview
Founded in 1965 by Umberto Veronesi and colleagues, AIRC funds investigator grants, the large multi-centre 5x1000 programmes, fellowships and start-up grants, and is the largest non-governmental funder of cancer research in Italy. It has supported the Milan groups behind breast-conserving surgery, sentinel node biopsy and the molecular oncology of leukaemia, and continues to fund immunotherapy, metastasis and early-detection programmes. AIRC's public campaigns (Oranges for Health, Azaleas for Research) are a national fixture, and its FIRC-Institute of Molecular Oncology (IFOM) in Milan is a dedicated research institute.
Location
Milan, IT
Type
consortium
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#506 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Italian Association for Cancer Research, including child institutions. 30 works · 343 citations · 97% open access · 3% clinical trials · 0% reviews.
Oncology works per year
102022
62023
92024
32025
22026
Most works
- Matthias Bernd Schulze5 works
- Rosario Tumino5 works
- Rudolf Kaaks4 works
- Marc James Gunter4 works
- Elisabete Weiderpass4 works
- María‐José Sánchez4 works
- Henk A. Mallo3 works
- Francesca Romana Berrini3 works
- Antonio Silvani3 works
- Catia Leuzzi3 works
Most cited
- Investigator grants and 5x1000 programmes
- IFOM institute
- Fellowships and early-career awards
- Public fundraising campaigns
Alberto Bardelli
Scientific Director, IFOM ETS - The AIRC Institute of Molecular Oncology; Professor, University of Turin
Colorectal cancer genomicsLiquid biopsyAcquired resistance
Used ctDNA to show how colorectal cancers evolve resistance to EGFR antibodies and how that resistance can fade.
Andrea Sironi
President of Fondazione AIRC per la ricerca sul cancro
Charity governanceCancer research fundingEconomics
President of Fondazione AIRC, the Italian charitable foundation that raises funds from the public to finance cancer research across the country.
Pier Giuseppe Pelicci
Director of Research, IEO; Professor, University of Milan
Cancer biologyLeukaemiaCancer stem cells
Molecular oncologist who characterised PML-RARα in acute promyelocytic leukaemia and studies cancer stem cells.
Giuseppe Curigliano
Director, Early Drug Development Division, IEO; Professor of Medical Oncology, University of Milan
Breast cancerEarly drug developmentHER2-low disease
Breast oncologist and phase 1 leader who co-led DESTINY-Breast06 and shaped the HER2-low concept.